National registry for children with Juvenile Idiopathic Arthritis in Canada
Official title: The Canadian Alliance of Pediatric Rheumatology Investigators National Juvenile Idiopathic Arthritis Registry
Run by University of British Columbia · NCT03245801 · Data updated 2026-11-12
This study is collecting information about children in Canada with Juvenile Idiopathic Arthritis to see how the disease affects them and how different treatments work over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 18 Years |
| Sex | All |
| Enrollment | 1238 (estimated) |
| Sponsor | University of British Columbia Academic / other |
| Drugs / interventions | methotrexate |
| Locations | 15 sites (Calgary, Alberta and 14 other locations) |
| Status | Recruiting |
| Started | February 1, 2017 |
| Main results expected | February 1, 2026 |
| Study ends | February 1, 2026 |
| Registry record updated | June 25, 2025 |
| Trial ID | NCT03245801 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry are children newly diagnosed with JIA within the last three months.
✕Probably not a fit
Patients with an unconfirmed JIA diagnosis or those diagnosed more than three months prior may not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The CAPRI National Juvenile Idiopathic Arthritis Registry collects longitudinal data on Canadian children diagnosed with Juvenile Idiopathic Arthritis (JIA) to better understand the disease's course, outcomes, and adverse events. This observational registry aims to inform healthcare decisions and improve treatment strategies by leveraging data from pediatric rheumatology experts across Canada. By tracking newly diagnosed patients and those from previous studies, the registry seeks to provide insights into the effectiveness of various treatment approaches and the overall prognosis for affected children.
Why it matters
Potential benefit: If successful, this registry could lead to improved treatment strategies and better health outcomes for children with Juvenile Idiopathic Arthritis.
How similar studies have gone: Other registries and studies focused on JIA have shown success in improving understanding and treatment of the condition, indicating that this approach is promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. All patients newly diagnosed with JIA within the last 3 months 2. All patients who participated in the original ReACCh-Out study 3. LEAP study patients from 'newly diagnosed' and 'ReACCh-Out' cohorts who have completed their two year follow up in LEAP Exclusion Criteria: 1. Patients with an unconfirmed JIA diagnosis 2. Patients diagnosed with JIA more than 3 months prior to the clinic visit, who were not followed in LEAP and /or ReACCh-Out studies. 3. If the family as a whole is unable to answer questionnaires in English or French
Where it's running
-
University of Calgary / Alberta Children's Hospital
Calgary, Alberta, Canada Recruiting -
University of Alberta
Edmonton, Alberta, Canada Recruiting -
BC Children's Hospital
Vancouver, British Columbia, Canada Recruiting -
University of Manitoba/Children's hospital research institute
Winnipeg, Manitoba, Canada Recruiting -
Memorial University/Janeway Childrens Health and Rehabilitation Centre
St. John's, Newfoundland and Labrador, Canada, Canada Recruiting -
IIWK Health Centre
Halifax, Nova Scotia, Canada Recruiting
Show 9 more locations
-
McMaster University/McMaster Children's Hospital
Hamilton, Ontario, Canada Recruiting -
London Health Sciences Centre
London, Ontario, Canada Recruiting -
Children's Hospital of Eastern Ontario
Ottawa, Ontario, Canada Recruiting -
Hospital for Sick Children
Toronto, Ontario, Canada Recruiting -
McGill University Health Centre
Montreal, Quebec, Canada Recruiting -
Université de Montréal
Montreal, Quebec, Canada Recruiting -
University of Sherbrooke
Sherbrooke, Quebec, Canada Recruiting -
Royal University Hospital
Saskatoon, Saskatchewan, Canada Recruiting -
CHU Québec - Universite Laval
Québec, Canada Recruiting
Study contacts
- Principal investigator: Adam Huber, MD — IIWK Health Centre, Halifax, Nova Scotia, Canada
- Study coordinator: Jaime Guzman, MD, FRCPC
- Email: jguzman@cw.bc.ca
- Phone: 604-875-2437
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting the course of early-onset juvenile idiopathic arthritis using a multidimensional model
Researchers are testing a comprehensive model to predict how early-onset JIA will progress in affected children and how a small control group with iridocyclitis compares.
-
Understanding subtypes of chronic musculoskeletal pain in youth
This observational study tests whether distinct brain and immune profiles can explain chronic musculoskeletal pain in teens and young adults to guide more precise treatments.
-
Open-label extension with filgotinib for juvenile idiopathic arthritis
This long-term open-label extension sees if filgotinib stays safe and continues to control symptoms in children aged 8–17 with polyarticular or systemic juvenile idiopathic arthritis who benefited from earlier treatment.
-
Structured or video-game–based core stabilization for children with juvenile idiopathic arthritis
This study will try whether a regular structured core exercise program or a fun exergaming-based core program helps children aged 8–13 with juvenile idiopathic arthritis improve strength, reduce pain, and move better.
-
Tofacitinib in Juvenile Idiopathic Arthritis
This study looks at real-world use of tofacitinib to see if it helps control Juvenile Idiopathic Arthritis in kids over about 12 months.
-
Parents' pain catastrophizing in children with juvenile idiopathic arthritis
See if parents' worrying and negative thoughts about their child's pain are linked to treatment adherence and biopsychosocial outcomes in children with juvenile idiopathic arthritis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.